Aclarubicin in Single Agent and Combined Chemotherapy of Adult Acute Myeloid Leukemia
The present contribution summarizes the results of treating acute myeloid leukemia (AML) with aclarubicin (ACM) in three consecutive studies. Some of the results have recently been published elsewhere [1–3].
KeywordsCytosine Arabinoside Combine Chemotherapy Antineoplastic Treatment Adult Acute Myeloid Leukemia Acute Nonlymphocytic Leukemia
Unable to display preview. Download preview PDF.